𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

✍ Scribed by Dr. George R. Uhl; Donna Walther; Deborah Mash; Baptiste Faucheux; France Javoy-Agid

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
570 KB
Volume
35
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

No correlation of substantia nigra echog
No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease
✍ Elmar Lobsien; Simon Schreiner; Michail Plotkin; Andreas Kupsch; Stephan J. Schr πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 758 KB

## Abstract ## Background: Substantia nigra hyperechogenicity assessed by transcranial sonography is a typical finding in up to 90% of patients with idiopathic Parkinson's disease, although its value as a surrogate marker for disease progression in Parkinson's disease is controversial. ^123^I‐FP‐C

Substantia nigra hyperechogenicity as a
Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease
✍ Katherine J. Schweitzer; RΓΌdiger Hilker; Uwe Walter; Lothar Burghaus; Daniela Be πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound mar